G/MA/QR/N/KGZ/1/Add.1 4 
7 de febrero  de 2022 
(22-0924) Página: 1/10 
Comité de Acceso a los Mercados  Original:  inglés  
 
  
NOTIFICACIÓN DE CONFORMIDAD CON LA DECISIÓN SOBRE EL  
PROCEDIMIENTO DE NOTIFICACIÓN DE RESTRICCIONES  
CUANTITATIVAS (G/L/59/REV.1)  
REPÚBLICA KIRGUISA  
Addendum  
La siguiente comunicación, de fecha 2 de febrero  de 202 2, se distribuye a petición de la delegación 
de la República Kirguisa.  
 
A. Miembro notificante: República Kirguisa  
B. Fecha de la notificación: 26 de enero  de 202 2 
C. Primera notificación:  
 Sí 
 No, la última notificación se presentó con la signatura (signatura del documento): 
G/MA/QR/N/KGZ/ 1/Add. 13 
D. Tipo de notificación:  
 1. Completa (es decir, notificación de todas las restricciones cuantitativas en vigor)  
 2. Cambios de una notificación present ada anteriormente con la signatura 
G/MA/QR/N/KGZ/1  consistentes en lo siguiente:  
  2.1 Establecimiento de nuevas restricciones, enumeradas en la sección 1.  
  2.2 Eliminación de restricciones, como se describe en la casilla G infra. 
  2.3 Modificación de una restricción notificada anteriormente, como se indica en la 
sección 1.  
 3. Notificación inversa de restricciones mantenidas por (Miembro):  
E. La notificación proporciona información sobre el siguiente período bienal: 
2020-2022 y se refiere a restricciones en vigor al  26 de enero  de 202 2 
F. La presente notificación contiene información1 relativa a:  
 Sección 1:  Lista de restricciones cuantitativas actualmente en vigor.  
 Sección 2:  Referencia a otras notificaciones presentadas a la OMC que contengan 
información sobre restricciones cuantitativas actualmente en vigor e 
información adicional.  
 
1 En inglés solamente.  G/MA/QR/N/KGZ/1/Add. 14 
- 2 - 
  G. Observaciones de carácter general, con inclusión de una descripción de la 
eliminación de restricciones notific ada en el apartado 2.2 de la casilla D y la fecha 
en que esas restricciones dejaron de estar en vigor.  
De conformidad con e l Decreto del Gobierno  de la República Kirguisa N º 14, de fecha 14 de enero 
de 2022 , la restricción temporal a la exportación de medi camentos y productos médicos  de la 
República Kirguisa entra en vigor el 9 de febrero de 2022.  Esta medida temporal se ha introducido 
en respuesta a la pandemia de COVID -19 y seguirá en vigor durante seis meses. Si la República 
Kirguisa adopta medidas adici onales, presentará una notificación pertinente .   
  G/MA/QR/N/KGZ/1/Add.1 4 
- 3 - 
 
Section 1: List of quantitative restrictions that are currently in force  
 
No General description 
of the restriction  Type of 
restriction  
 Tariff line code(s) 
affected, based on 
HS (2012)  Detailed Product 
Description  WTO Justification 
and Grounds for 
Restriction, e.g., 
Other International 
Commitments  National legal 
basis and entry 
into force  
 Administration, modification 
of previously notified 
measures,  
and other comments  
 1 2 3 4 5 6 7 
1 Temporary export 
prohibition of  
medicines and 
medical products   CP-X  1. Medicines  GATT Article XI:(2)(a)  
 
GATT Article XX(b)  
 Decree of 
Government of the 
Kyrgyz Republic #14 
dated 14.01.2022  
 
The decree enters 
into force on 
09.02.2022 and will 
cease to be in force 
on 09.08.2022.  The Government of the Kyrgyz 
Republic adopted decree #14, 
dated 14.01.2022, on the 
introduction of a temporary ban 
for six months  on medicines and 
medical products from the 
Kyrgyz Republic. The 
abovementioned decree enters 
into force on 09.02.2022.  
 
The measure is valid until 
09.08.2022  
 
It is necessary to follow both the 
HS code and the name of 
medicine s and medical products;  
 
Exports for the purpose of 
humanitarian assistance are 
excluded from this export 
restriction.  
    2804 40  000 0  Medical oxygen   
   3002 12  000 3  Immunoglobulin G   
   3002 12 000 5  Fresh frozen plasma   
   3002 15 000 0  Alteplase   
   3004 10 000 5  Amoxicillin   
   3004 10 000 5  Amoxicillin + 
clavulanic acid   
   3004 10 000 8  Piperacillin + beta -
lactamase inhibitor   
   3004 20 000 1  Amikacin    
   3004 20 000 2  Cefepime + beta -
lactamase inhibitor    
   3004 20 000 2  Cefotaxime    
   3004 20 000 2  Ceftazidime    
   3004 20 000 2  Cefuroxime axetil    
   3004 20 000 2  Ciprofloxacin    
   3004 20 000 2  Clarithramycin    
   3004 20  000 2  Clindamycin    
   3004 20 000 2  Linezolid    
   3004 20 000 2  Meropenem    
   3004 20 000 2  Vancomycin    
   3004 32 000 8  Dexamethasone    
   3004 32 000 9  Hydrocortisone    
   3004 32  000 9  Methylprednisolone    
   3004 32  000 9  Prednisolone    
   3004 39 000  Dopamine    
   3004 39 000  Epinephrine    
   3004 49 000 8  Codeine, 
combinations      
  G/MA/QR/N/KGZ/1/Add.1 4 
- 4 - 
 
No General description 
of the restriction  Type of 
restriction  
 Tariff line code(s) 
affected, based on 
HS (2012)  Detailed Product 
Description  WTO Justification 
and Grounds for 
Restriction, e.g., 
Other International 
Commitments  National legal 
basis and entry 
into force  
 Administration, modification 
of previously notified 
measures,  
and other comments  
 1 2 3 4 5 6 7 
   3004 90 000 2  Acetylcysteine    
   3004 90 000 2  Ambroxol    
   3004 90 000 2  Apixaban    
   3004 90 000 2  Bromhexine    
   3004 90 000 2  Butamirat    
   3004 90 000 2  Dabigatran    
   3004 90 000 2  Dalteparin    
   3004 90  000 2  Diphenhydramine    
   3004 90 000 2  Dobutamine    
   3004 90  000 2  Domperidone    
   3004 90 000 2  Edoxaban    
   3004 90 000 2  Enoxaparin    
   3004 90 000 2  Famotidine    
   3004 90 000 2  Fluconazole    
   3004 90 000 2  Fondaparinux    
   3004 90 000 2  Heparin    
   3004 90 000 2  Ibuprofen    
   3004 90  000 2  Imipinem / 
cilastatin    
   3004 90 000 2  Ketamine    
   3004 90 000 2  Lansoprazole    
   3004 90 000 2  Loperamide    
   3004 90 000 2  Metoclopramide    
   3004 90 000 2  Omeprazole    
   3004 90 000 2  Ondansetron    
   3004 90 000 2  Oral rehydration 
salts   
   3004 90 000 2  Pantoprazole    
   3004 90 000 2  Pipecuronium 
bromide    
   3004 90 000 2  Prenoxdiazine    
   3004 90 000 2  Protamine sulfate    
   3004 90 000 2  Ringer's solution    
   3004 90 000 2  Rivaraxaban    
   3004 90 000 2  Salbutamol    
   3004 90 000 2  Sodium acetate + 
sodium chloride      
  G/MA/QR/N/KGZ/1/Add.1 4 
- 5 - 
 
No General description 
of the restriction  Type of 
restriction  
 Tariff line code(s) 
affected, based on 
HS (2012)  Detailed Product 
Description  WTO Justification 
and Grounds for 
Restriction, e.g., 
Other International 
Commitments  National legal 
basis and entry 
into force  
 Administration, modification 
of previously notified 
measures,  
and other comments  
 1 2 3 4 5 6 7 
   3004 90 000 2  Sodium acetate + 
sodium chloride + 
potassium chloride    
   3004 90 000 2  Sodium chloride    
   3004 90 000 2  Streptokinase    
   3004 90 000 2  Suxamethonium    
   3004 90 000 2  Urokinase    
   3004 90 000 8  Codeine, 
combinations    
    2. Medical devices    
   3005 10 000 0  Adhesive plaster    
   3005 90 100 0  Medical cotton wool    
   3005 90 310 0  Gauze    
   3822 12 000 9  Coronavirus 
reagents kit    
   3822 12 000 9  Immunochemical 
analysis reagents kit    
   3822 12 000 9  Needle sensitivity 
disks   
   3822 19 000 9  Coronavirus 
reagents kit    
   3822 19 000 9  Immunochemical 
analysis reagents kit    
   3822 19 000 9  Needle sensitivity 
disks   
   3822 90 000 0  Coronavirus 
reagents kit    
   3822 90 000 0  Immunochemical 
analysis reagents kit    
   3822 90 000 0  Needle sensitivity 
disks   
   3926 20 000 0  Inspection gloves    
   3926 90 970 9  Box for 
transportation of 
patients infected 
with dangerous viral 
infections    
   4015 11 000 0  Surgical gloves      
  G/MA/QR/N/KGZ/1/Add.1 4 
- 6 - 
 
No General description 
of the restriction  Type of 
restriction  
 Tariff line code(s) 
affected, based on 
HS (2012)  Detailed Product 
Description  WTO Justification 
and Grounds for 
Restriction, e.g., 
Other International 
Commitments  National legal 
basis and entry 
into force  
 Administration, modification 
of previously notified 
measures,  
and other comments  
 1 2 3 4 5 6 7 
   8419 89 981 0  Plasma defroster    
   8514 30 000 0  Destructor for 
needles    
   9018 11 000 0  ECG machine    
   9018 19 100 0  Bedside monitor    
   9018 19 100 0  Capnographer    
   9018 19 100 0  Pulse Oximeter    
   9018 20 000 0  Bactericidal 
recirculator    
   9018 39 000 0  Central venous 
catheters    
   9018 39 000 0  Nasal cannulas    
   9018 39 000 0  Nasogastric tubes    
   9018 39 000 0  Oxygen therapy 
nasopharyngeal 
catheters    
   9018 39 000 0  Syringe needles 
(wide bore)    
   9018 90 100 0  Blood pressure 
monitor (tonometer)    
   9018 90 200 0  Laryngoscope    
   9018 90 500 9  Drip infusion pump    
   9018 90 500 9  Infusion systems    
   9018 90 500 9  Syringe infusion 
pump    
   9018 90 600 0  Oronasal masks    
   9018 90 840 9  Blood glucose meter 
with test strips    
   9018 90 840 9  Bobrov's apparatus    
   9018 90 840 9  Box for 
transportation of 
patients infected 
with dangerous viral 
infections    
   9018 90 840 9  Cuffed tracheal tube    
   9018 90 840 9  Defibrillator    
   9018 90 840 9  Gas analyzers    
   9018 90 840 9  IV stand      
  G/MA/QR/N/KGZ/1/Add.1 4 
- 7 - 
 
No General description 
of the restriction  Type of 
restriction  
 Tariff line code(s) 
affected, based on 
HS (2012)  Detailed Product 
Description  WTO Justification 
and Grounds for 
Restriction, e.g., 
Other International 
Commitments  National legal 
basis and entry 
into force  
 Administration, modification 
of previously notified 
measures,  
and other comments  
 1 2 3 4 5 6 7 
   9018 90 840 9  Laryngoscope    
   9018 90 840 9  Otoscope    
   9018 90 840 9  Stainless Steel 
Tongue Depressor 
Set   
   9019 20 000 0  BPAP ventilator    
   9019 20 000 0  CPAP machine    
   9019 20 000 0  Inhaler    
   9019 20 000 0  Manual breathing 
apparatus for adults    
   9019 20 000 0  Manual breathing 
apparatus for 
children    
   9019 20 000 0  Oxygen bag    
   9019 20 000 0  Oxygen 
concentrator    
   9019 20 000 0  Reservoir bag 
masks    
   9019 20 000 0  Ventilator portable    
   9019 20 000 0  Ventilator stationary    
   9019 31 100 9  Injection syringes, 
single use    
   9022 14 000 0  Mobile X -ray 
machine    
   9022 14 000 0  Stationary X -ray 
apparatus    
   9025 19 200 0  Thermometer IR    
   9027 10 900 0  Gas analyzers    
   9027 50 000 0  Thermal imager 
(portable)    
   9027 50 000 0  Thermal imager 
(stationary)    
   9027 80 170 0  Blood glucose meter 
with test strips    
   9027 89 000 0  Coagulometer    
   9402 90 000 0  Functional bed 3 -
section      
  G/MA/QR/N/KGZ/1/Add.1 4 
- 8 - 
 
No General description 
of the restriction  Type of 
restriction  
 Tariff line code(s) 
affected, based on 
HS (2012)  Detailed Product 
Description  WTO Justification 
and Grounds for 
Restriction, e.g., 
Other International 
Commitments  National legal 
basis and entry 
into force  
 Administration, modification 
of previously notified 
measures,  
and other comments  
 1 2 3 4 5 6 7 
   9402 90 000 0  Medical furniture 
(bed + curbstone + 
table)    
   9402 90 000 0  Medical instrument 
trolleys    
   3702 10  000 0  X-ray film for 
medical printer    
   4015 19  000 0  Inspection gloves    
   8443 32 100 9  Medical X -ray 
Printer    
   8539 49  000 0  Germicidal lamp    
   9006 59  000 8  Medical X -ray 
Printer    
   9018 12  000 0  Echocardiogram 
machines    
   9018 12  000 0  Ultrasound machine   
   9018 39  000 0  Sterile swab   
   9018 90  500 1  Blood transfusion 
systems    
   9018 90  500 9  Blood collection 
syringes   
   9018 90  840 9  Endotracheal tube 
without cuff   
   9018 90  840 9  Guedel airway kit, 
sterile, disposable 
(several sizes)  
 9018 90  840 9  Sterile swab  
9018 90 840 9  Surgical suction  
9019 20  000 0  Nebulizer  
9020 00  000 0  Oxygen Therapy 
Full Face Mask  
  9022 12  000 0  Computer 
tomograph    
2 Temporary export 
authorithation of 
medicines and 
medical products   NAL-X 3004 10 000 1  Ampicillin  GATT Article XI:(2)(a)  
 
GATT Article XX(b)  
 Decree of 
Government of the 
Kyrgyz Republic #14 
dated 14.01.2022  
 The Government of the Kyrgyz 
Republic adopted decree #14, 
dated 14.01.2022, on the 
introduction of a temporary ban 
for six months  on medicines and  3004 20 000 2  Azithromycin  
 3004 20 000 2  Cefepim  
 3004 20 000 2  Ceftriaxone  
 3004 90 000 2  Paracetamol    
  G/MA/QR/N/KGZ/1/Add.1 4 
- 9 - 
 
No General description 
of the restriction  Type of 
restriction  
 Tariff line code(s) 
affected, based on 
HS (2012)  Detailed Product 
Description  WTO Justification 
and Grounds for 
Restriction, e.g., 
Other International 
Commitments  National legal 
basis and entry 
into force  
 Administration, modification 
of previously notified 
measures,  
and other comments  
 1 2 3 4 5 6 7 
 3004 90 000 6  Acetylsalicylic acid  The decree enters 
into force on 
09.02.2022 and will 
cease to be in force 
on 09.08.2022.  medical products from the 
Kyrgyz Republic. The 
abovementioned decree enters 
into force on 09.02.2022.  
 
The measure is valid until 
09.08.2022  
 
It is necessary to follow both the 
HS code and the name of 
medicines and medical products;  
 
Exports for the purpo se of 
humanitarian assistance are 
excluded from this export 
restriction.  
 
Export of these medicines and 
medical goods classified under 
the EAEU HS codes is allowed on 
the basis of:  
 
- the conclusion on the 
purposefulness of export issued 
by the Ministry of  Health of the 
Kyrgyz Republic for each batch of 
exported goods, containing 
information on the 
nomenclature, quantity, value of 
such goods, as well as on the 
organizations that carry out the 
export;  
 
- the presence of a certificate of 
origin of the goods i n the Kyrgyz 
Republic;  
 
 
 
  3005 90 500 0  Masks, half masks, 
respirator masks, 
respirator  
 4818 90 100 0  Masks, half masks, 
respirator masks, 
respirator  
  4818 90 900   Masks, half masks, 
respirator masks, 
respirator  
   6307 90 980 0  Masks, half masks, 
respirator masks, 
respirator     
  G/MA/QR/N/KGZ/1/Add.1 4 
- 10 - 
 
No General description 
of the restriction  Type of 
restriction  
 Tariff line code(s) 
affected, based on 
HS (2012)  Detailed Product 
Description  WTO Justification 
and Grounds for 
Restriction, e.g., 
Other International 
Commitments  National legal 
basis and entry 
into force  
 Administration, modification 
of previously notified 
measures,  
and other comments  
 1 2 3 4 5 6 7 
       - on the basis of the conclusion 
of the Ministry of Health of the 
Kyrgyz Republic for the export of 
artificial lung ventilation (ALV) 
devices previously imported into 
the territory of the Kyrgyz 
Republic.  
 
 
 
 
__________